Genetically engineered whole-cell sensing systems: coupling biological recognition with reporter genes
Daunert, S.; Barrett, G.; Feliciano, J.S.; Shetty, R.S.; Shrestha, S.; Smith-Spencer, W.
Chemical Reviews 100(7): 2705-2738
2000
ISSN/ISBN: 0009-2665 PMID: 11749302 Document Number: 515559
Document emailed within 1 workday
Related Documents
Moiseev, S.V.; Novikov, P.I.; Semenkova, E.N.; Strizhakov, L.A.; Gulyaev, S.V.; Yanushkevich, T.N.; Nikiforova, N.V.; Meshkov, A.D.; Panasyuk, V.V.; Sokorin, Y.D.; Taranova, M.V.; Parfenova, S.A.; Dubrovskaya, L.V.; Zhabina, E.S.; Kuznetsova, E.I.; Lopatina, I.A.; Bulanov, N.M.; Mukhin, N.A. 2013: Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases Terapevticheskii Arkhiv 85(5): 37-43Sandstrom, P.A.; Folks, T.M. 2001: Facilitated detection of adventitious agents using genetically engineered cell lines Developments in Biologicals 106: 375-378; Discussion: 379-380
Nishihara, K.; Barth, R.F.; Wilkie, N.; Lang, J.C.; Oda, Y.; Kikuchi, H.; Everson, M.P.; Lotze, M.T. 1995: Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha Cancer Gene Therapy 2(2): 113-124
Chou, W.G.; Zhu, W.; Salim, M.; Rehman, S.; Tate-Ostroff, B.; Majocha, R.E.; Sajdel-Sulkowska, E.M.; Marotta, C.A.; Zain, S.B. 1989: Extracytoplasmic and A4 domains of the amyloid precursor protein: molecular cloning, genetically engineered cell lines and immunocytochemical investigations Progress in Clinical and Biological Research 317: 991-999
MacDonald, C.; Brzeski, H. 1987: Strategies for the isolation of genetically manipulated animal cell lines expressing novel genes Developments in Biological Standardization 66: 65-70
Kurihara, H. 2006: Genetically-engineered model animals Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 5): 267-272
Clackson, T.P. 1991: Genetically engineered monoclonal antibodies British Journal of Rheumatology 30(Suppl 2): 36-39
Cima, G. 2010: FDA considering approval of genetically engineered salmon Journal of the American Veterinary Medical Association 237(9): 1005-1007
Koda, T.; Togashi, Y.; Nishimura, T. 2002: Genetically engineered mice and its application to bioindustry Hokkaido Journal of Medical Science 77(2): 151-156
Colcher, D.; Pavlinkova, G.; Beresford, G.; Booth, B.J.; Choudhury, A.; Batra, S.K. 1998: Pharmacokinetics and biodistribution of genetically-engineered antibodies Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 42(4): 225-241
Doetschman, T. 1999: Interpretation of phenotype in genetically engineered mice Laboratory Animal Science 49(2): 137-143
Gorlach, K. 1994: Problems in the introduction of genetically engineered microorganisms into the environment Acta Microbiologica Polonica 43(2): 121-131
Hunter, G.; Burns, L.; Bone, B.; Mintel, T.; Jimenez, E. 2012: Usability research study of a specially engineered sonic powered toothbrush with unique sensing and control technologies Journal of Clinical Dentistry 23(Special Issue A): A31-A34
Iwamoto, T.; Kita, S.; Shigekawa, M. 2002: Functional analysis of Na+/Ca2+ exchanger using novel drugs and genetically engineered mice Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 120(1): 91p-93p
Parren, P.W. 1992: Preparation of genetically engineered monoclonal antibodies for human immunotherapy Human Antibodies and Hybridomas 3(3): 137-145
Yoshida, S.; Shimada, Y.; Watanabe, H. 2007: Novel approach toward infectious diseases--combating malaria by using genetically engineered mosquitoes Nihon Rinsho. Japanese Journal of Clinical Medicine 65(9): 1715-1726
Rockman, H.A.; Koch, W.J.; Lefkowitz, R.J. 1997: Cardiac function in genetically engineered mice with altered adrenergic receptor signaling American Journal of Physiology 272(4 Pt 2): H1553-H1559
Zitvogel, L.; Tahara, H.; Robbins, P.D.; Storkus, W.J.; Clarke, M.R.; Nalesnik, M.A.; Lotze, M.T. 1995: Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts Journal of Immunology 155(3): 1393-1403
Markert, J.M.; Parker, J.N.; Gillespie, G.Y.; Whitley, R.J. 2001: Genetically engineered human herpes simplex virus in the treatment of brain tumours Herpes: the Journal of the Ihmf 8(1): 17-22
Ivankin, A.N.; Mitaleva, S.I.; Nekliudov, A.D. 1998: Biosynthesis and isolation of a recombinant protein for producing genetically-engineered human proinsulin Prikladnaia Biokhimiia i Mikrobiologiia 34(3): 293-299